(19)
(11) EP 4 447 684 A1

(12)

(43) Date of publication:
23.10.2024 Bulletin 2024/43

(21) Application number: 22840077.6

(22) Date of filing: 16.12.2022
(51) International Patent Classification (IPC): 
A01N 43/90(2006.01)
A01P 5/00(2006.01)
 A01N 51/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A01N 43/90; A01N 51/00
(86) International application number:
PCT/EP2022/086499
(87) International publication number:
WO 2023/111333 (22.06.2023 Gazette 2023/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 17.12.2021 US 202163291136 P

(71) Applicants:
  • Bayer Animal Health GmbH
    51373 Leverkusen (DE)
  • ELANCO US INC.
    Greenfield, IN 46140 (US)

(72) Inventors:
  • RINGEISEN, Hannah
    40789 Monheim am Rhein (DE)
  • PETRY, Gabriele
    40789 Monheim am Rhein (DE)
  • SCHAPER, Roland
    51381 Leverkusen (DE)
  • BÖHM, Claudia
    30457 Hannover (DE)
  • POLLMEIER, Matthias
    40593 Düsseldorf (DE)

(74) Representative: Cohausz & Florack 
Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14
40211 Düsseldorf
40211 Düsseldorf (DE)

   


(54) TOPICAL ADMINISTRATION OF COMPOSITION COMPRISING 10% W/V IMIDACLOPRID AND 1% W/V MOXIDECTIN FOR THE TREATMENT OF TROGLOSTRONGYLOSIS IN CATS